ImmunityBio, a clinical-stage immunotherapy company, has completed its acquisition of the leasehold interest in an ISO Class 5 pharmaceutical manufacturing space in western New York from global pharmaceutical company Athenex. The new state-of-the-art biotech production facility, located in Dunkirk, NY (Chautauqua County), includes clean rooms for upstream and downstream manufacturing activities, as well as fill and finish and large-scale lyophilization capabilities. The full-scale facility en...